Ahmad Gharaibeh Profile
Ahmad Gharaibeh

@gharaibeh_a

Followers
506
Following
2K
Media
2
Statuses
149

Incoming Cardiology Fellow at @BUcards, Internal Medicine Resident at @CCF_IMCHIEFS 🫀⚡️| Tweets are my own.

Amman, Hashemite Kingdom of Jo
Joined December 2011
Don't wanna be here? Send us removal request.
@Dr_Santangeli
Pasquale Santangeli
5 months
Post-pacing interval after failed anti-tachycardia pacing for scar-related ventricular tachycardia: implications for the location of the critical substrate @EuropaceEiC @CleClinicHVTI @KojiHiguchiCCF https://t.co/XzS7P55nVT
0
34
112
@Dr_Santangeli
Pasquale Santangeli
6 months
Management of ventricular tachycardia in patients with advanced heart failure @ioanliuba @SroubekJ @CleClinicHVTI https://t.co/jlt5MFjiG1
1
11
69
@omwazni
Oussama Wazni
6 months
0
5
20
@CleClinicHVTI
Cleveland Clinic Heart, Vascular & Thoracic
6 months
@Dr_Santangeli provides an overview of presentations from @ClevelandClinic’s Ventricular Tachycardia Center at #HRS2025🫀 @omwazni @tavrkapadia @CCFcards
0
5
30
@gregorymmarcus
Greg Marcus
8 months
Significantly less acute brain emboli among left ventricular catheter ablation patients randomized to a transseptal versus a retrograde aortic approach per our @PCORI-funded #TRAVERSE trial. Thank you to our patients who helped design and implement the study, my generous EP
6
42
105
@Dr_Santangeli
Pasquale Santangeli
9 months
Percutaneous VT Ablation via RA-to-LV Access in Patients With Double Mechanical Valves: A Multicenter Registry https://t.co/hD9iDOeHLy @konsiont @CleClinicHVTI @JACCJournals @shivkumarmd
5
46
151
@Dr_Santangeli
Pasquale Santangeli
9 months
PVI With Pentaspline PFA From an Axillary Venous Approach in a Patient with Interrupted IVC: First US Report @CleClinicHVTI @tavrkapadia @BalintLaczay https://t.co/AZEEa9iN4f
4
20
98
@BUcards
BMC|BU Cardiology Fellows
11 months
Thrilled to introduce the @BUcards incoming fellowship class of 2025! Truly an impressive roster of future leaders in cardiology! Excited to welcome you all to @The_BMC @SophMercadante @RatiVani7 @akpritch @gharaibeh_a #paulfranco #scottplace #alexschmidt
2
3
44
@Dr_Santangeli
Pasquale Santangeli
11 months
With up to 32% early post-procedural mortality, VT ablation in the emergency setting is among the highest risk procedures in cardiology and cardiothoracic surgery. Read the Vanderbilt experience ( https://t.co/TO6ePj4vPh) and our commentary ( https://t.co/gc5NW7kog6) @shivkumarmd
2
35
106
@DCharabaty
Aline Charabaty, MD, FACG, AGAF
11 months
#SundayRead☕️ #IBD therapies & serious AE at 3yrs 🔺Biologics: ⬇️risk CV (MI, stroke), VTE, mortality vs non users 🔺Small molecules: No differce in AE vs nonusers, but ⬇️overall mortality, incl. in🔺Pt> age50 +CV risk factor @IBDJournals @DinaAlayan https://t.co/NjWuakkSIH
2
46
139
@medpedshosp
Med Peds Hospitalist
11 months
@gharaibeh_a 👇🏻
@ENARM_intensivo
ENARM ⚡ Intensivo 💯👨🏻‍⚕️🩺📚🔬
11 months
🌀PRESIONES INTRACARDIACAS #ENARM_INTENSIVO #ENARM2025 #ENARM
0
2
2
@DrHebaMD
heba wassif
11 months
@AkivaRosenzveig⁩ presenting our data on the risk of stroke and mitral annular calcification. . ⁦@CCF_IMCHIEFS⁩ ⁦@CleClinicHVTI⁩ ⁦@ClevelandClinic
2
4
33
@arwayounis2
Arwa Younis MD
11 months
Exciting news to our patients. A big milestone in AF management. Congratulations @omwazni on this very important @NEJM publication. The OPTION trial: #WatchmanFlex non-inferior to DOACs for stroke prevention, with a 23% lower major bleeding rate. #AHA2024 @CleClinicHVTI #epeeps
0
8
65
@DrRohitMoudgil
Rohit Moudgil MD PhD
1 year
Great Work by Lorenzo and team to look at Bonaco Criteria and it's relevance to cardiovascular outcomes in the biggest single center study. Very relevant and important for all cardio-oncologist. @DSadlerMD @TomasNeilan @ICOSociety @CardioOncology @PalaskasN @ACCinTouch
@LorenzoBragh
Lorenzo Braghieri, MD 🇮🇹🇺🇸🇪🇺
1 year
What started as a simple idea in residency @CCF_IMCHIEFS is now published @ESCHeartFailure ! Hope this further helps clinicians in this challenging scenario. Thanks to all co-authors @DrRohitMoudgil @venumenon10 @FunchainMD @CCalabreseDO @CCFcards @CleClinicHVTI
0
5
32
@LorenzoBragh
Lorenzo Braghieri, MD 🇮🇹🇺🇸🇪🇺
1 year
What started as a simple idea in residency @CCF_IMCHIEFS is now published @ESCHeartFailure ! Hope this further helps clinicians in this challenging scenario. Thanks to all co-authors @DrRohitMoudgil @venumenon10 @FunchainMD @CCalabreseDO @CCFcards @CleClinicHVTI
2
7
66
@omwazni
Oussama Wazni
1 year
#GlobalEPSummit Day 1 world class presentations and discussions by expert faculty from ⁦@CleClinicHVTI⁩ and around the world
0
13
50
@Dr_Santangeli
Pasquale Santangeli
1 year
Elimination of Epicardial Scar-Related Ventricular Tachycardia With Endocardial Pulsed Field Ablation: First Clinical Report @CleClinicHVTI @omwazni @SroubekJ https://t.co/dcaUtRmwLJ
9
62
220
@Mud_Fud
Richard M. Wardrop III, MD, PhD, MACP, SFHM, FAAP
1 year
Amazing work Dr. @HadilZureigat and team! @CCF_IMCHIEFS are so proud of you! @CleClinicGME #IMProud
@moaathmustafaal
Moaath Mustafa Ali, MD, MPH | د. معاذ مصطفى علي
1 year
🔬 In this study led by the magnificent @HadilZureigat , we showed that existence of 2 Hematopath classifications, ICC and WHO, for Myeloid/ Lymphoid neoplasm is a cause of confusion to doctors. We call for a unified classification. @HadidiSamer @KMirza @Mud_Fud @CCF_IMCHIEFS
1
3
9
@LorenzoBragh
Lorenzo Braghieri, MD 🇮🇹🇺🇸🇪🇺
1 year
Humbled to share our PoC study showing the ability of real-world data to generate clinical evidence for cardiac lead safety. Feels extra special since @BruceWilkoff kept on pushing us to never give up. Grateful for the guidance by @leonard_ganz . @Mud_Fud @venumenon10 @CCFcards
2
10
36